Ketamine Oral Rinse in the Management of Oral Mucositis in Head and Neck Cancer Patients Undergoing Radiation Therapy

Phase: PHASE2 | Sponsor: University of Oklahoma | Compound: Ketamine

Status

planned

Institution

University of Oklahoma

Start date

2024-11-01

End date

2027-11-01

Registry ID

NCT06660017

View trial record

Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.